2023-2029 Global Antipyretic and Analgesic Drugs Industry Research & Trends Analysis Report
This report aims to provide a comprehensive study of the global market for Antipyretic and Analgesic Drugs.
Report Highlights:
(1) Global Antipyretic and Analgesic Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Antipyretic and Analgesic Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Antipyretic and Analgesic Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Antipyretic and Analgesic Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Antipyretic and Analgesic Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Antipyretic and Analgesic Drugs, capacity, production and trends.
(7) Antipyretic and Analgesic Drugs industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for Antipyretic and Analgesic Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Antipyretic and Analgesic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Antipyretic and Analgesic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Ibuprofen segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Antipyretic and Analgesic Drugs include Mallinckrodt, SKPL, Pfizer, Sanofi, Bayer, China National Medicines Guorui Pharmaceutical, Baotai Pharmaceutical, Huaan Pharmaceutical and Yuanhe Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
Ibuprofen
Paracetamol
Analgin
Naproxen
Aspirin
Others
By Applications, the market is segmented into:
Hospital
Clinic
Key Players Driving the Market:
Mallinckrodt
SKPL
Pfizer
Sanofi
Bayer
China National Medicines Guorui Pharmaceutical
Baotai Pharmaceutical
Huaan Pharmaceutical
Yuanhe Pharmaceutical
Heping Pharmaceutical
Hongxing Pharmaceutical
Xinhui Pharmaceutical
Dingchang Pharmaceutical
Topfond Pharmaceutical
Taile Pharmaceutical
Kys Pharm
China Resources Double-Crane Pharmaceutical
1 Market Overview
1.1 Antipyretic and Analgesic Drugs Definition
1.2 Global Antipyretic and Analgesic Drugs Market Size and Forecast
1.2.1 By Revenue, Global Antipyretic and Analgesic Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Antipyretic and Analgesic Drugs Market Size, 2018-2029
1.2.3 Global Antipyretic and Analgesic Drugs Price Trend, 2018-2029
1.3 China Antipyretic and Analgesic Drugs Market Size and Forecast
1.3.1 By Revenue, China Antipyretic and Analgesic Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Antipyretic and Analgesic Drugs Market Size, 2018-2029
1.3.3 China Antipyretic and Analgesic Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Antipyretic and Analgesic Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Antipyretic and Analgesic Drugs Share in Global Market, 2018-2029
1.4.3 Antipyretic and Analgesic Drugs Market Size: China VS Global, 2018-2029
1.5 Antipyretic and Analgesic Drugs Market Dynamics
1.5.1 Antipyretic and Analgesic Drugs Market Drivers
1.5.2 Antipyretic and Analgesic Drugs Market Restraints
1.5.3 Antipyretic and Analgesic Drugs Industry Trends
1.5.4 Antipyretic and Analgesic Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Antipyretic and Analgesic Drugs Revenue by Company, 2018-2023
2.2 Global Antipyretic and Analgesic Drugs Sales Volume by Company, 2018-2023
2.3 Global Antipyretic and Analgesic Drugs Price by Company, 2018-2023
2.4 Global Antipyretic and Analgesic Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Antipyretic and Analgesic Drugs Concentration Ratio
2.6 Global Antipyretic and Analgesic Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Antipyretic and Analgesic Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Antipyretic and Analgesic Drugs Revenue by Company, 2018-2023
3.2 China Antipyretic and Analgesic Drugs Sales Volume by Company, 2018-2023
3.3 China Antipyretic and Analgesic Drugs Antipyretic and Analgesic Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Antipyretic and Analgesic Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Antipyretic and Analgesic Drugs Domestic VS Export
3.6 China Market, Antipyretic and Analgesic Drugs Import & Export
3.6.1 China Market, Antipyretic and Analgesic Drugs Import & Export, 2018-2029
3.6.2 China Antipyretic and Analgesic Drugs Import & Export Trends
3.6.3 Main Sources of China Antipyretic and Analgesic Drugs Import
3.6.4 Export Destination of China Antipyretic and Analgesic Drugs
4 Antipyretic and Analgesic Drugs Production by Region
4.1 Global Antipyretic and Analgesic Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Antipyretic and Analgesic Drugs Manufacturers
4.3 Global Major Manufacturers, Antipyretic and Analgesic Drugs Capacity Expansion and Future Plans
4.4 Global Antipyretic and Analgesic Drugs Capacity by Region
4.5 Global Antipyretic and Analgesic Drugs Production by Region
4.5.1 Global Antipyretic and Analgesic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Antipyretic and Analgesic Drugs Production by Region, 2018-2023
4.5.3 Global Antipyretic and Analgesic Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Antipyretic and Analgesic Drugs Industry Chain
5.2 Antipyretic and Analgesic Drugs Upstream Analysis
5.2.1 Antipyretic and Analgesic Drugs Core Raw Materials
5.2.2 Main Manufacturers of Antipyretic and Analgesic Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Antipyretic and Analgesic Drugs Production Mode
5.6 Antipyretic and Analgesic Drugs Procurement Model
5.7 Antipyretic and Analgesic Drugs Industry Sales Model and Sales Channels
5.7.1 Antipyretic and Analgesic Drugs Sales Model
5.7.2 Antipyretic and Analgesic Drugs Typical Distributors
6 Sights by Type
6.1 Antipyretic and Analgesic Drugs Classification
6.1.1 Ibuprofen
6.1.2 Paracetamol
6.1.3 Analgin
6.1.4 Naproxen
6.1.5 Aspirin
6.1.6 Others
6.2 By Type, Global Antipyretic and Analgesic Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029
6.4 By Type, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029
6.5 By Type, Global Antipyretic and Analgesic Drugs Price, 2018-2029
7 Sights by Application
7.1 Antipyretic and Analgesic Drugs Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Antipyretic and Analgesic Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029
7.4 By Application, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029
7.5 By Application, Global Antipyretic and Analgesic Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Antipyretic and Analgesic Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029
8.3 By Region, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Antipyretic and Analgesic Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Antipyretic and Analgesic Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Antipyretic and Analgesic Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Antipyretic and Analgesic Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Antipyretic and Analgesic Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Antipyretic and Analgesic Drugs Market Size Market Share
8.7 South America
8.7.1 South America Antipyretic and Analgesic Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Antipyretic and Analgesic Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Antipyretic and Analgesic Drugs Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029
9.3 By Country, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.6.2 By Company, China Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.10.2 By Company, India Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Antipyretic and Analgesic Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Mallinckrodt
10.1.1 Mallinckrodt Company Information, Head Office, Market Area and Industry Position
10.1.2 Mallinckrodt Antipyretic and Analgesic Drugs Models, Specifications and Application
10.1.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Mallinckrodt Company Profile and Main Business
10.1.5 Mallinckrodt Recent Developments
10.2 SKPL
10.2.1 SKPL Company Information, Head Office, Market Area and Industry Position
10.2.2 SKPL Antipyretic and Analgesic Drugs Models, Specifications and Application
10.2.3 SKPL Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 SKPL Company Profile and Main Business
10.2.5 SKPL Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.3.2 Pfizer Antipyretic and Analgesic Drugs Models, Specifications and Application
10.3.3 Pfizer Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Sanofi
10.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.4.2 Sanofi Antipyretic and Analgesic Drugs Models, Specifications and Application
10.4.3 Sanofi Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sanofi Company Profile and Main Business
10.4.5 Sanofi Recent Developments
10.5 Bayer
10.5.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.5.2 Bayer Antipyretic and Analgesic Drugs Models, Specifications and Application
10.5.3 Bayer Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Bayer Company Profile and Main Business
10.5.5 Bayer Recent Developments
10.6 China National Medicines Guorui Pharmaceutical
10.6.1 China National Medicines Guorui Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.6.2 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.6.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 China National Medicines Guorui Pharmaceutical Company Profile and Main Business
10.6.5 China National Medicines Guorui Pharmaceutical Recent Developments
10.7 Baotai Pharmaceutical
10.7.1 Baotai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.7.2 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.7.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Baotai Pharmaceutical Company Profile and Main Business
10.7.5 Baotai Pharmaceutical Recent Developments
10.8 Huaan Pharmaceutical
10.8.1 Huaan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.8.2 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.8.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Huaan Pharmaceutical Company Profile and Main Business
10.8.5 Huaan Pharmaceutical Recent Developments
10.9 Yuanhe Pharmaceutical
10.9.1 Yuanhe Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.9.2 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.9.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Yuanhe Pharmaceutical Company Profile and Main Business
10.9.5 Yuanhe Pharmaceutical Recent Developments
10.10 Heping Pharmaceutical
10.10.1 Heping Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.10.2 Heping Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.10.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Heping Pharmaceutical Company Profile and Main Business
10.10.5 Heping Pharmaceutical Recent Developments
10.11 Hongxing Pharmaceutical
10.11.1 Hongxing Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.11.2 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.11.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Hongxing Pharmaceutical Company Profile and Main Business
10.11.5 Hongxing Pharmaceutical Recent Developments
10.12 Xinhui Pharmaceutical
10.12.1 Xinhui Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.12.2 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.12.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Xinhui Pharmaceutical Company Profile and Main Business
10.12.5 Xinhui Pharmaceutical Recent Developments
10.13 Dingchang Pharmaceutical
10.13.1 Dingchang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.13.2 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Dingchang Pharmaceutical Company Profile and Main Business
10.13.5 Dingchang Pharmaceutical Recent Developments
10.14 Topfond Pharmaceutical
10.14.1 Topfond Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.14.2 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.14.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Topfond Pharmaceutical Company Profile and Main Business
10.14.5 Topfond Pharmaceutical Recent Developments
10.15 Taile Pharmaceutical
10.15.1 Taile Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.15.2 Taile Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.15.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Taile Pharmaceutical Company Profile and Main Business
10.15.5 Taile Pharmaceutical Recent Developments
10.16 Kys Pharm
10.16.1 Kys Pharm Company Information, Head Office, Market Area and Industry Position
10.16.2 Kys Pharm Antipyretic and Analgesic Drugs Models, Specifications and Application
10.16.3 Kys Pharm Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Kys Pharm Company Profile and Main Business
10.16.5 Kys Pharm Recent Developments
10.17 China Resources Double-Crane Pharmaceutical
10.17.1 China Resources Double-Crane Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.17.2 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
10.17.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 China Resources Double-Crane Pharmaceutical Company Profile and Main Business
10.17.5 China Resources Double-Crane Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Antipyretic and Analgesic Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Antipyretic and Analgesic Drugs Market Restraints
Table 3. Antipyretic and Analgesic Drugs Market Trends
Table 4. Antipyretic and Analgesic Drugs Industry Policy
Table 5. Global Antipyretic and Analgesic Drugs Revenue by Company, 2018-2023, US$ million
Table 6. Global Antipyretic and Analgesic Drugs Revenue Market Share by Company, 2018-2023
Table 7. Global Antipyretic and Analgesic Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Antipyretic and Analgesic Drugs Sales Volume Market Share by Company, 2018-2023
Table 9. Global Antipyretic and Analgesic Drugs Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Antipyretic and Analgesic Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Antipyretic and Analgesic Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Antipyretic and Analgesic Drugs Manufacturers Product Type
Table 13. China Antipyretic and Analgesic Drugs Revenue by Company, 2018-2023, US$ million
Table 14. China Antipyretic and Analgesic Drugs Revenue Market Share by Company, 2018-2023
Table 15. China Antipyretic and Analgesic Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Antipyretic and Analgesic Drugs Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Antipyretic and Analgesic Drugs Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Antipyretic and Analgesic Drugs Import & Export Trends
Table 19. Main Sources of China Antipyretic and Analgesic Drugs Import
Table 20. Export Destination of China Antipyretic and Analgesic Drugs
Table 21. Global Headquarters and Manufacturing Base of Antipyretic and Analgesic Drugs Manufacturers
Table 22. Global Major Manufacturers, Antipyretic and Analgesic Drugs Capacity Expansion and Future Plans
Table 23. Global Antipyretic and Analgesic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Antipyretic and Analgesic Drugs Production by Region, 2018-2023, (K Units)
Table 25. Global Antipyretic and Analgesic Drugs Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Antipyretic and Analgesic Drugs Upstream (Raw Materials)
Table 27. Global Antipyretic and Analgesic Drugs Typical Customers
Table 28. Antipyretic and Analgesic Drugs Typical Distributors
Table 29. By Type, Global Antipyretic and Analgesic Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Antipyretic and Analgesic Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Antipyretic and Analgesic Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Antipyretic and Analgesic Drugs Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Antipyretic and Analgesic Drugs Revenue Market Share, 2018-2029
Table 37. By Country, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Antipyretic and Analgesic Drugs Sales Volume Market Share, 2018-2029
Table 39. Mallinckrodt Company Information, Head Office, Market Area and Industry Position
Table 40. Mallinckrodt Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 41. Mallinckrodt Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Mallinckrodt Company Profile and Main Business
Table 43. Mallinckrodt Recent Developments
Table 44. SKPL Company Information, Head Office, Market Area and Industry Position
Table 45. SKPL Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 46. SKPL Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. SKPL Company Profile and Main Business
Table 48. SKPL Recent Developments
Table 49. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 50. Pfizer Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 51. Pfizer Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Pfizer Company Profile and Main Business
Table 53. Pfizer Recent Developments
Table 54. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 55. Sanofi Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 56. Sanofi Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sanofi Company Profile and Main Business
Table 58. Sanofi Recent Developments
Table 59. Bayer Company Information, Head Office, Market Area and Industry Position
Table 60. Bayer Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 61. Bayer Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bayer Company Profile and Main Business
Table 63. Bayer Recent Developments
Table 64. China National Medicines Guorui Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 65. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 66. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. China National Medicines Guorui Pharmaceutical Company Profile and Main Business
Table 68. China National Medicines Guorui Pharmaceutical Recent Developments
Table 69. Baotai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 70. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 71. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Baotai Pharmaceutical Company Profile and Main Business
Table 73. Baotai Pharmaceutical Recent Developments
Table 74. Huaan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 75. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 76. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Huaan Pharmaceutical Company Profile and Main Business
Table 78. Huaan Pharmaceutical Recent Developments
Table 79. Yuanhe Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 80. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 81. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Yuanhe Pharmaceutical Company Profile and Main Business
Table 83. Yuanhe Pharmaceutical Recent Developments
Table 84. Heping Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 85. Heping Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 86. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Heping Pharmaceutical Company Profile and Main Business
Table 88. Heping Pharmaceutical Recent Developments
Table 89. Hongxing Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 90. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 91. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Hongxing Pharmaceutical Company Profile and Main Business
Table 93. Hongxing Pharmaceutical Recent Developments
Table 94. Xinhui Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 95. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 96. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Xinhui Pharmaceutical Company Profile and Main Business
Table 98. Xinhui Pharmaceutical Recent Developments
Table 99. Dingchang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 100. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 101. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Dingchang Pharmaceutical Company Profile and Main Business
Table 103. Dingchang Pharmaceutical Recent Developments
Table 104. Topfond Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 105. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 106. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Topfond Pharmaceutical Company Profile and Main Business
Table 108. Topfond Pharmaceutical Recent Developments
Table 109. Taile Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 110. Taile Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 111. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Taile Pharmaceutical Company Profile and Main Business
Table 113. Taile Pharmaceutical Recent Developments
Table 114. Kys Pharm Company Information, Head Office, Market Area and Industry Position
Table 115. Kys Pharm Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 116. Kys Pharm Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Kys Pharm Company Profile and Main Business
Table 118. Kys Pharm Recent Developments
Table 119. China Resources Double-Crane Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 120. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications and Application
Table 121. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. China Resources Double-Crane Pharmaceutical Company Profile and Main Business
Table 123. China Resources Double-Crane Pharmaceutical Recent Developments
List of Figure
Figure 1. Antipyretic and Analgesic Drugs Picture
Figure 2. By Revenue, Global Antipyretic and Analgesic Drugs Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Antipyretic and Analgesic Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Antipyretic and Analgesic Drugs Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Antipyretic and Analgesic Drugs Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Antipyretic and Analgesic Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Antipyretic and Analgesic Drugs Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Antipyretic and Analgesic Drugs Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Antipyretic and Analgesic Drugs Share of Global Market, 2018-2029
Figure 10. Global Antipyretic and Analgesic Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Antipyretic and Analgesic Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Antipyretic and Analgesic Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Antipyretic and Analgesic Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Antipyretic and Analgesic Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Antipyretic and Analgesic Drugs Domestic VS Export, 2022
Figure 16. Global Antipyretic and Analgesic Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Antipyretic and Analgesic Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Antipyretic and Analgesic Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 19. Antipyretic and Analgesic Drugs Industry Chain
Figure 20. Antipyretic and Analgesic Drugs Procurement Model
Figure 21. Antipyretic and Analgesic Drugs Sales Model
Figure 22. Antipyretic and Analgesic Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Ibuprofen
Figure 24. Paracetamol
Figure 25. Analgin
Figure 26. Naproxen
Figure 27. Aspirin
Figure 28. Others
Figure 29. By Type, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029, US$ Million
Figure 30. By Type, Global Antipyretic and Analgesic Drugs Revenue Market Share, 2018-2029
Figure 31. By Type, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 32. By Type, Global Antipyretic and Analgesic Drugs Sales Volume Market Share, 2018-2029
Figure 33. By Type, Global Antipyretic and Analgesic Drugs Price, 2018-2029, (US$/Unit)
Figure 34. Hospital
Figure 35. Clinic
Figure 36. By Application, Global Antipyretic and Analgesic Drugs Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Antipyretic and Analgesic Drugs Revenue Market Share, 2018-2029
Figure 38. By Application, Global Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global Antipyretic and Analgesic Drugs Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Antipyretic and Analgesic Drugs Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global Antipyretic and Analgesic Drugs Revenue Market Share, 2018-2029
Figure 42. By Region, Global Antipyretic and Analgesic Drugs Sales Volume Market Share, 2018-2029
Figure 43. North America Antipyretic and Analgesic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America Antipyretic and Analgesic Drugs Revenue Market Share, 2022
Figure 45. Europe Antipyretic and Analgesic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe Antipyretic and Analgesic Drugs Revenue Market Share, 2022
Figure 47. Asia Pacific Antipyretic and Analgesic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific Antipyretic and Analgesic Drugs Revenue Market Share, 2022
Figure 49. South America Antipyretic and Analgesic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America Antipyretic and Analgesic Drugs Revenue Market Share, 2022
Figure 51. Middle East & Africa Antipyretic and Analgesic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, U.S. Antipyretic and Analgesic Drugs Market Share, 2022
Figure 54. By Type, U.S. Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, Europe Antipyretic and Analgesic Drugs Market Share, 2022
Figure 58. By Type, Europe Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 60. China Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, China Antipyretic and Analgesic Drugs Market Share, 2022
Figure 62. By Type, China Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, Japan Antipyretic and Analgesic Drugs Market Share, 2022
Figure 66. By Type, Japan Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, South Korea Antipyretic and Analgesic Drugs Market Share, 2022
Figure 70. By Type, South Korea Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, Southeast Asia Antipyretic and Analgesic Drugs Market Share, 2022
Figure 74. By Type, Southeast Asia Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 76. India Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, India Antipyretic and Analgesic Drugs Market Share, 2022
Figure 78. By Type, India Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Antipyretic and Analgesic Drugs Sales Volume, 2018-2029, (K Units)
Figure 81. By Company, Middle East & Asia Antipyretic and Analgesic Drugs Market Share, 2022
Figure 82. By Type, Middle East & Asia Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Antipyretic and Analgesic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|